Literature DB >> 7606007

Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.

F M Gill1, L A Sleeper, S J Weiner, A K Brown, R Bellevue, R Grover, C H Pegelow, E Vichinsky.   

Abstract

Within the Cooperative Study of Sickle Cell Disease, 694 infants with confirmed sickle cell disease were enrolled at less than 6 months of age. Information about the nature and frequency of complications was collected prospectively over a 10-year period. Painful crises and acute chest syndrome were the most common sickle cell-related events in homozygous sickle cell anemia (SS), hemoglobin SC disease (SC), and S beta thalassemia patients (overall incidence in SS patients of 32.4 and 24.5 cases per 100 person-years, respectively). Bacteremia occurred most frequently in SS children under 4 years of age and in SC patients less than 2 years of age. The mortality rate was low in this cohort compared with that found in previous reports. Twenty children, all with Hb SS, died (1.1 deaths per 100 person-years among SS patients). Infection, most commonly with Streptococcus pneumoniae and Hemophilus influenzae, caused 11 deaths. Two children died of splenic sequestration, 1 of cerebrovascular accident, and 6 of unclear causes. Two patients underwent cholecystectomies, and 17 underwent splenectomies after one or more splenic sequestration crises. The experience of this cohort should reflect closely the true clinical course of those children with Hb SS and Hb SC disease who are observed in sickle cell centers in the United States.

Entities:  

Mesh:

Year:  1995        PMID: 7606007

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  124 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.

Authors:  Mehdi Nouraie; Noel S Reading; Andrew Campbell; Caterina P Minniti; Sohail R Rana; Lori Luchtman-Jones; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Josef T Prchal; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

3.  Complications of sickle cell anaemia in children in Northwestern Tanzania.

Authors:  Hamza Saidi; Luke R Smart; Erasmus Kamugisha; Emmanuela E Ambrose; Deogratias Soka; Robert N Peck; Julie Makani
Journal:  Hematology       Date:  2016-02-17       Impact factor: 2.269

Review 4.  Dactylitis: pathogenesis and clinical considerations.

Authors:  Paul J Healy; Philip S Helliwell
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

5.  Current sickle cell disease management practices in Nigeria.

Authors:  N Galadanci; B J Wudil; T M Balogun; G O Ogunrinde; A Akinsulie; F Hasan-Hanga; A S Mohammed; M O Kehinde; J A Olaniyi; I N Diaku-Akinwumi; B J Brown; S Adeleke; O E Nnodu; I Emodi; S Ahmed; A O Osegbue; N Akinola; H I O Opara; S A Adegoke; J Aneke; A D Adekile
Journal:  Int Health       Date:  2013-10-10       Impact factor: 2.473

6.  Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I.

Authors:  Gregory J Kato
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

7.  Asthma in children with sickle cell disease and its association with acute chest syndrome.

Authors:  J M Knight-Madden; T S Forrester; N A Lewis; A Greenough
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

8.  Outcomes of febrile events in pediatric patients with sickle cell anemia.

Authors:  Krishnaveni Sirigaddi; Inmaculada Aban; Amelia Jantz; Brandi M Pernell; Lee M Hilliard; Smita Bhatia; Jeffrey D Lebensburger
Journal:  Pediatr Blood Cancer       Date:  2018-08-01       Impact factor: 3.167

9.  Definitions of the phenotypic manifestations of sickle cell disease.

Authors:  Samir K Ballas; Susan Lieff; Lennette J Benjamin; Carlton D Dampier; Matthew M Heeney; Carolyn Hoppe; Cage S Johnson; Zora R Rogers; Kim Smith-Whitley; Winfred C Wang; Marilyn J Telen
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

10.  Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.

Authors:  Susan T Paulukonis; James R Eckman; Angela B Snyder; Ward Hagar; Lisa B Feuchtbaum; Mei Zhou; Althea M Grant; Mary M Hulihan
Journal:  Public Health Rep       Date:  2016 Mar-Apr       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.